血清C反应蛋白与血红蛋白比值:诊断慢性假体周围关节感染的新型生物标志物
本研究纳入2010年1月至2022年12月共841例翻修关节置换病例(435例假体周围关节感染(PJI)和406例非PJI患者),评估C反应蛋白(CRP)、红细胞沉降率(ESR)及其组合比值对PJI的诊断价值。结果显示,CRP与血红蛋白比值(CHR)的曲线下面积(0.87,95%CI 0.85至0.90)和敏感性(0.81,95%CI 0.77至0.85)最高,对低毒力病原体所致PJI诊断效能可靠,但在糖尿病患者中敏感性较低(0.77,95%CI 0.67至0.86)。
要点
- CHR诊断慢性PJI的AUC为0.87(95%CI 0.85至0.90),敏感性0.81(95%CI 0.77至0.85),优于其他标志物。
- CHR对低毒力病原体所致PJI的敏感性0.83(95%CI 0.76至0.89),特异性0.83(95%CI 0.79至0.86)。
- CHR在糖尿病患者中敏感性为0.77(95%CI 0.67至0.86),诊断效能较低。
核心结论
- CHR在检测慢性PJI方面比其他经典标志物具有更好的诊断强度,尤其是在识别低度感染方面。
- 研究结果为更准确、全面地了解病原体和宿主提供了新见解,从而提高诊断算法的准确性。
研究设计与样本
- 本研究纳入2010年1月至2022年12月共841例翻修关节置换病例,其中435例PJI和406例非PJI患者。
- 采用敏感性、特异性和受试者工作特征曲线分析(曲线下面积)评估CRP、ESR、CRP+ESR、CHR、CRP与白蛋白比值、CRP与血红蛋白+白蛋白比值、ESR与血红蛋白比值、ESR与白蛋白比值、ESR与血红蛋白+白蛋白比值及血红蛋白+白蛋白的诊断价值。
- 使用约登指数确定最佳阈值。
主要发现
- CHR的曲线下面积最高(0.87,95%CI 0.85至0.90),敏感性最高(0.81,95%CI 0.77至0.85)。
- CHR对低毒力病原体所致PJI的敏感性为0.83(95%CI 0.76至0.89),特异性为0.83(95%CI 0.79至0.86)。
- CHR在糖尿病患者中敏感性为0.77(95%CI 0.67至0.86)。
关键数值与推荐
- CHR的曲线下面积为0.87(95%CI 0.85至0.90),敏感性0.81(95%CI 0.77至0.85)。
- CHR对低毒力病原体所致PJI的敏感性0.83(95%CI 0.76至0.89),特异性0.83(95%CI 0.79至0.86)。
- CHR在糖尿病患者中敏感性0.77(95%CI 0.67至0.86)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite several markers being evaluated and available in recent years, diagnosing periprosthetic joint infection (PJI) remains challenging. There is a pressing need to explore reliable, economical, convenient, highly sensitive, and specific diagnostic biomarkers to diagnose PJI. This study aimed to investigate the diagnostic value of combined serum markers with C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in PJI. METHODS: A total of 841 revision arthroplasty cases, including 435 PJI and 406 non-PJI patients, were enrolled from January 2010 through December 2022. The diagnostic values of CRP, ESR, CRP + ESR, CRP or hemoglobin ratio (CHR), CRP or albumin ratio, CRP or hemoglobin + albumin ratio, ESR or hemoglobin ratio, ESR or albumin ratio, ESR or hemoglobin + albumin ratio, and hemoglobin + albumin were evaluated using sensitivity, specificity, and receiver operating characteristics analysis with area under the curve. The optimal threshold was determined using the Youden index. RESULTS: The CHR had the highest area under the curve (0.87, 95% CI [confidence interval] 0.85 to 0.90) and sensitivity (0.81, 95% CI: 0.77 to 0.85), compared to other markers. The CHR exhibited reliable diagnostic adequacy for PJIs caused by low-virulent organisms (sensitivity 0.83, 95% CI: 0.76 to 0.89; specificity 0.83, 95% CI: 0.79 to 0.86). However, CHR displayed poor sensitivity (0.77, 95% CI: 0.67 to 0.86) in patients who have diabetes. CONCLUSIONS: The CHR demonstrated better diagnostic strength in detecting chronic PJI than other classical markers, especially in identifying low-grade infections. Our findings offer new insights into a more accurate and comprehensive picture of pathogens and hosts, thereby improving the accuracy of diagnostic algorithms.
引用
- Aimaiti A, Guo W, Xu B, et al. Serum C-Reactive Protein to Hemoglobin Ratio: Novel Biomarkers for the Diagnosis of Chronic Periprosthetic Joint Infection. J Arthroplasty. 2025. PMID: 39978653. doi:10.1016/j.arth.2025.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。